Phospholipase A2: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
PLA2 serve as pharmacological targets for therapeutical treatment of diseases like atherosclerosis, immune disorders, cardiovascular diseases and cancer<ref>PMID:24907600</ref>. Reduced Lp-PLA2 activity is observed in patients with severe sepsis. There is association between the level of Lp-PLA2 in plasma and the risk of future cardiovascular events<ref>PMID:19272461</ref>. | PLA2 serve as pharmacological targets for therapeutical treatment of diseases like atherosclerosis, immune disorders, cardiovascular diseases and cancer<ref>PMID:24907600</ref>. Reduced Lp-PLA2 activity is observed in patients with severe sepsis. There is association between the level of Lp-PLA2 in plasma and the risk of future cardiovascular events<ref>PMID:19272461</ref>. | ||
==Diclofenac binding to Phospholipase A2== | ==Diclofenac binding to Phospholipase A2<ref>PMID:PMID:25237841</ref>== | ||
'''Abstract from Pubmed''' | '''Abstract from Pubmed''' | ||